BlackRock »

Lenz Therapeutics shares owned by BlackRock

Quarter-by-quarter ownership of Lenz Therapeutics (LENZ) shares owned by BlackRock from 13F filings

Historical chart of BlackRock investment in Lenz Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Lenz Therapeutics held by BlackRock consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lenz Therapeutics by BlackRock

Quarter filed Position value Share count Share price at filing
2024-06-30 $17M 960k 17.29
2024-03-31 $5.4M 241k 22.33

More positions owned by BlackRock

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
Broadcom (AVGO)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)
Tesla Motors (TSLA)
UnitedHealth (UNH)
Ishares Tr Core S&p500 Etf (IVV)
Exxon Mobil Corporation (XOM)

View all positions for BlackRock

Top funds holding Lenz Therapeutics

RA Capital Management
Falcon Edge Capital
EcoR1 Capital
Samsara BioCapital
72 Investment Holdings
BlackRock
Vanguard Group
BlackRock
Point72 Asset Management
Tang Capital Management
T. Rowe Price Associates
Geode Capital Management
State Street Corporation
Ikarian Capital
Northern Trust

View all funds holding Lenz Therapeutics